These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8255017)

  • 41. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
    Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
    Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duration of protection by oxitropium bromide against cholinergic challenge.
    Wilson NM; Green S; Coe C; Barnes PJ
    Eur J Respir Dis; 1987 Nov; 71(5):455-8. PubMed ID: 3327703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aminophylline upon the exercise performance of patients with stable chronic airflow obstruction.
    Nietrzeba RM; Elliott CG; Adams TD; Yeh MP; Yanowitz FG
    Bull Eur Physiopathol Respir; 1984; 20(4):361-7. PubMed ID: 6478093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a B2 adrenergic agonist and an anticholinergic agent given by sequential inhalation in patients with severe chronic obstructive pulmonary disease.
    Heimer D; Brami JL; Liberman D; Bark H
    Isr J Med Sci; 1991 Jun; 27(6):307-10. PubMed ID: 1676394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I; Van Schil L; Van der Veken J
    Eur J Clin Pharmacol; 1994; 46(4):305-7. PubMed ID: 7957513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bronchodilator effects of an atropinic compound: oxitropium pressurized aerosol. Comparison with theophylline in asthma].
    Gayrard P; Orehek J
    Rev Pneumol Clin; 1984; 40(4):273-4. PubMed ID: 6545469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients.
    Ukena D; Wehinger C; Engelstätter R; Steinijans V; Sybrecht GW
    Eur Respir J; 1993 Mar; 6(3):378-82. PubMed ID: 8472828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of supplemental oxygen on exercise performance in patients with chronic obstructive pulmonary disease and an arterial oxygen tension over 60 Torr].
    Ishimine A; Saito H; Nishimura M; Nakano T; Miyamoto K; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):510-9. PubMed ID: 7609336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the bronchodilating effect of oxitropium bromide and fenoterol in asthmatic children.
    Van Bever HP; Desager KN; Pauwels JH; Vermeire PA
    Eur J Pediatr; 1994 Aug; 153(8):604-6. PubMed ID: 7957410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
    Wesseling G; Mostert R; Wouters EF
    Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance.
    Tobin MJ; Hughes JA; Hutchison DC
    Eur J Respir Dis; 1984 Aug; 65(6):441-6. PubMed ID: 6236095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitussive properties of inhaled bronchodilators on induced cough.
    Lowry R; Wood A; Johnson T; Higenbottam T
    Chest; 1988 Jun; 93(6):1186-9. PubMed ID: 2967164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.
    Taube C; Kanniess F; Grönke L; Richter K; Mücke M; Paasch K; Eichler G; Jörres RA; Magnussen H
    Respir Med; 2003 May; 97(5):568-77. PubMed ID: 12735677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
    Fujimura M; Kamio Y; Matsuda T; Hashimoto T
    Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.